Phospholipase signalling pathways in thyroxine-induced cardiac hypertrophy.
Williams
S
S
Division of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Winnipeg, Manitoba, Canada.
Mesaeli
N
N
Panagia
V
V
D000818:Animals; D006332:Cardiomegaly / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology*; D009206:Myocardium / Q000201:enzymology*; D010716:Phosphatidylinositols / Q000378:metabolism; D010739:Phospholipase D / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values; D012508:Sarcolemma / Q000201:enzymology; D015398:Signal Transduction; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood; D010738:Type C Phospholipases / Q000378:metabolism*
D010716:Phosphatidylinositols; D014284:Triiodothyronine; D010738:Type C Phospholipases; D010739:Phospholipase D; D013974:Thyroxine